Corbus Pharmaceuticals Holdings (CRBP) Revenue (QoQ) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) Revenue (QoQ) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -28.73% |
| Jun 30, 2021 | -78.92% |
| Mar 31, 2021 | -62.36% |
| Dec 31, 2020 | 39.85% |
| Sep 30, 2020 | 329.77% |
| Jun 30, 2020 | -83.75% |
| Mar 31, 2020 | 106.17% |
| Dec 31, 2019 | -1,203.18% |
| Sep 30, 2019 | -91.10% |
| Jun 30, 2019 | 1,442.92% |
| Mar 31, 2019 | 838.15% |
| Dec 31, 2018 | -81.57% |
| Sep 30, 2018 | 27.79% |
| Jun 30, 2018 | -10.18% |
| Sep 30, 2017 | 127.40% |
| Jun 30, 2017 | -72.93% |
| Sep 30, 2016 | 87.23% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 8.87% |
| Dec 31, 2015 | 113.72% |